SCHEMBL18231

SCHEMBL18231

C[C@H]1COCC(CO)N1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ncc(O)cn1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 11/20 0.50
GCKR Q14397 8/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899132 0.87 GCK (0.48) GCKGCKR
SCHEMBL33220 0.85 GCK (0.66) GCKGCKR
SCHEMBL12093429 0.85 GCK (0.47) GCKGCKR
SCHEMBL12089559 0.84 GCK (0.54) GCKGCKR
SCHEMBL18509 0.82 GCK (0.66) GCKGCKR
SCHEMBL17845 0.80 GCKR (0.57) GCKGCKR
SCHEMBL14899167 0.78 GCKR (0.59) GCKGCKR
SCHEMBL14899156 0.77 GCK (0.58) GCKGCKR
SCHEMBL14899172 0.77 GCK (0.58) GCKGCKR
SCHEMBL12089617 0.76 GCK (0.72) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed